Loblaw Financial Holdings Inc. v. Canada: A Closer Look at Canada’s FAPI Rules

By Thien Hoang On April 23, 2020, the Federal Court of Appeal (FCA) rendered its judgement in Loblaw Financial Holdings Inc. v. Canada, 2020 FCA 79, a case involving Loblaw Companies Ltd., Canada’s largest food and pharmacy chain. In its unanimous decision, the FCA reversed the judgement of the Tax Court of Canada (TCC) and …

Continue reading Loblaw Financial Holdings Inc. v. Canada: A Closer Look at Canada’s FAPI Rules

Just What the Doctor Ordered?: A Look at the Side Effects of Theratechnologies on Secondary Market Liability in Canada

By Stéphane Rousseau, Dominique Payette and Christopher Trouvé. Originally published on the Canadian Bar Review. The recent decision of the Supreme Court of Canada in Theratechnologies Inc. v 121851 Canada Inc. (“Thera”) goes to the heart of the debate on the place of the public and private enforcement methods in the Canadian securities regulation regime. Fundamentally, the case concerns …

Continue reading Just What the Doctor Ordered?: A Look at the Side Effects of Theratechnologies on Secondary Market Liability in Canada